Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker

Summary

Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker is a doctoral thesis^[1].

Key Facts

• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker authored Development as a Biomarker — author (P50): Nick Magon^[2].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's instance of is recorded as Development as a Biomarker — instance of (P31): doctoral thesis^[3].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's publisher is recorded as Development as a Biomarker — publisher (P123): OUR Archive^[4].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's language of work or name is recorded as Development as a Biomarker — language of work or name (P407): English^[5].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's country of origin is recorded as Development as a Biomarker — country of origin (P495): New Zealand^[6].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's publication date is recorded as +2013-00-00T00:00:00Z^[7].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's main subject is recorded as Development as a Biomarker — main subject (P921): biomarker^[8].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's main subject is recorded as Development as a Biomarker — main subject (P921): inflammatory bowel diseases^[9].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's main subject is recorded as Development as a Biomarker — main subject (P921): cystic fibrosis^[10].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's main subject is recorded as Development as a Biomarker — main subject (P921): myeloperoxidase^[11].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's main subject is recorded as Development as a Biomarker — main subject (P921): hypochlorous acid^[12].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's Handle ID is recorded as 10523/4118^[13].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's title is recorded as Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker^[14].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's copyright holder is recorded as Development as a Biomarker — copyright holder (P3931): Nick Magon^[15].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's thesis submitted to is recorded as Development as a Biomarker — thesis submitted to (P4101): University of Otago^[16].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's on focus list of Wikimedia project is recorded as Development as a Biomarker — on focus list of Wikimedia project (P5008): NZThesisProject^[17].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's copyright status is recorded as Development as a Biomarker — copyright status (P6216): copyrighted^[18].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's thesis committee member is recorded as Development as a Biomarker — thesis committee member (P9161): Mark Hampton^[19].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's thesis committee member is recorded as Development as a Biomarker — thesis committee member (P9161): Richard Gearry^[20].
• Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's thesis committee member is recorded as Development as a Biomarker — thesis committee member (P9161): Tony Kettle^[21].

Body

Designation and Status

Oxidative Modification of Calprotectin During Inflammation: Development as a Biomarker's instance of is recorded as Development as a Biomarker — instance of (P31): doctoral thesis^[3].